NLRP3 and hyperuricemia: The molecular mechanism of its specific action may be related to the inhibition of the TLR4/MyD88 signaling pathway and the NLRP3 inflammasome activation, thereby reducing IL-1β production in high fructose-induced hyperuricaemia mice [59].